|
|
1999
|
|
Yudong
Quan, Dimitrios Motakis, Robert W. Buckheit, Jr., Ze-Qi Xu,
Michael T. Flavin, Michael A. Parniak, and Mark A. Wainberg.
Sensitivity and Resistance to (+)-Calanolide A of Wild-Type
and Mutated Forms of HIV-1 Reverse Transcriptase.
Antiviral Therapy, 1999, 4, 203-209.
|
|
L.
A. Sorbera, P. Leeson, and J. Castaner.
Calanolide A.
Drugs of the Future, 1999, 24, 235-245.
|
|
Yuh-Meei
Lin, Herbert M. Anderson, Tuah R. Jenta, Michael J. Williams,
Michael T. Flavin, and Ze-Qi Xu.
An efficient and scalable method for the isolation of costatolide,
a naturally-occurring anti-HIV agent, from the latex of Calophyllum
teysmannii var. inophylloide.
Pharmaceutical Biology, 1999, 37, 71-76.
|
|
Ze-Qi
Xu, Melinda G. Hollingshead, Suzanne Gorgel, Cindy Elder,
Albert Khilevich, and Michael T. Flavin.
In vivo Anti-HIV Activity of (+)-Calanolide A in the Hollow
Fiber Mouse Model.
Bioorganic Medicinal Chemistry Letters, 1999, 9, 133-138.
|
|
Yuh-Meei
Lin, Michael T. Flavin, Ralph Schure, Fa-Ching Chen, Robert
Sidwell, Dale L. Barnard, John H. Huffman, and Earl Kern.
Antiviral Activities of Biflavonoids.
Planta Medica, 1999, 65, 120-125.
|
|
|
